SCIENTIFIC EVIDENCE

Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis

Open medicine (Warsaw, Poland)

Su L, Huang Y, Zheng L, Zhu Z, Wu Y, Li P.

Publication Overview

Key findings, Countstar context, and access to the original paper.

2022

Cancer Research

Key Finding

This study examines cell death in bile duct cancer.

Countstar Connection

The researchers assessed cell viability with the Countstar IC1000.

Stay Connected to

Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.

Meet us online